An investigation for investors in Blueprint Medicines Corporation (NASDAQ:BPMC) shares over potential securities laws violations by Blueprint Medicines Corporation was announced.

San Diego, CA -- (SBWire) -- 08/30/2022 --Blueprint Medicines Corporation is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Blueprint Medicines Corporation (NASDAQ: BPMC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Blueprint Medicines Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Cambridge, MA based Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

On August 17, 2022, before trading hours, Blueprint Medicines Corporation announced top-line results from the registrational Part 2 of its PIONEER clinical trial of AYVAKIT® (avapritinib) in patients with non-advanced systemic mastocytosis (SM). The results showed a deterioration in the absolute improvement in the symptom score from 15.6 points in this most recent trial versus 19.7 in Phase 1.

Shares of Blueprint Medicines Corporation (NASDAQ: BPMC) declined from $73.03 per share on August 12, 2022, to as low as $52.00 per share on August 17, 2022.

Those who purchased shares of Blueprint Medicines Corporation (NASDAQ: BPMC) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.